The article you requested is
Dr Chan and Colleagues Reply
J Clin Psychiatry 2011;72(7):1016-1017 [letter]
Copyright 2011 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $40
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
We appreciate the comments made by Peritogiannis and Tsouli regarding our recently published article. We agree that researchers should focus on studying the use of other second-generation antipsychotics (SGAs) to treat patients with SGA-induced tardive dyskinesia. This kind of study has both clinical and etiologic implications for tardive dyskinesia.